Establishes a generic drug research and development laboratory and production facility in New York to manufacture generic prescription drugs and.

New York A00500 amends the public health law to establish a generic drug research and development laboratory and production facility within the University of the State of New York system. This facility will produce and distribute generic prescription drugs, aiming to make them widely available to public and private purchasers. The first initiative of this facility will be the Empire State Biosimilar Insulin Initiative, focusing on developing generic forms of the three most widely used forms of insulin.

Establishes a generic drug research and development laboratory and production facility in New York to manufacture generic prescription drugs and.

New York A00500 amends the public health law to establish a generic drug research and development laboratory and production facility within the University of the State of New York system. This facility will produce and distribute generic prescription drugs, aiming to make them widely available to public and private purchasers. The first initiative of this facility will be the Empire State Biosimilar Insulin Initiative, focusing on developing generic forms of the three most widely used forms of insulin.